A significant step forward in ophthalmology innovation as PerZeption Inc. announces a collaboration with Alcon Research to advance next-generation visual assessment technologies. The announcement comes alongside new data being presented at the prestigious ARVO Annual Meeting.
At the event, PerZeption is showcasing its AIM+ CSF modeling technology, designed to deliver rapid, repeatable, and highly sensitive detection of clinically meaningful visual differences. The approach significantly reduces testing time achieving reliable results in under three minutes – while maintaining high accuracy and minimal patient burden.
The research highlights the system’s ability to detect subtle changes in contrast sensitivity with strong statistical power, reinforcing its value for vision correction evaluation and clinical research. This positions the technology as a scalable and efficient alternative to traditional testing methods.
By combining PerZeption’s adaptive, cloud-based platform with Alcon’s global expertise, the collaboration underscores a shared commitment to enhancing precision, accessibility, and efficiency in eye care diagnostics — marking a promising advancement for the future of ophthalmology.
Share your Details for subscribe